
|Podcasts|September 21, 2021
Dr. Allaway on the increased efficiency of transperineal biopsies
Author(s)Urology Times staff
“We need to do a better job sampling the prostate,” says Matthew J. Allaway, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Matthew J. Allaway, MD. He discusses how his new technology, The PrecisionPoint Transperineal Access System, is used for detecting prostate cancer in patients. Matthew J. Allaway, MD, is the founder and president of Perinealogic and a urologist and managing partner at Urology Associates, Cumberland, Maryland.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
2
Experts discuss the challenge of detecting CIS in bladder cancer
3
FDA grants tentative approval to generic olaparib tablets across previously approved indications
4
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
5












